Dr. Porter is a former Chairman of the Department of Medicine, and the first Chief of the Division of Nephrology, Hypertension and Clinical Pharmacology at OHSU. His research interests include the use of urinary biomarkers to identify toxic injury to the kidneys, and the value of serum biomarkers in chronic renal failure patients. In 1997, he was the recipient of the International Society of Nephrology’s E.G. Bywaters Award for life-long contributions to the field of Acute Renal Failure. He is a co-investigator of the National Analgesic Nephropathy study funded by NIH in 1999.

Degrees:

B.S. - Oregon State College, Corvallis, Oregon 1953
M.S., M.D.- University of Oregon Medical School, Portland, Oregon 1957

Residency:

Internal Medicine - University of Oregon Medical School, Portland, Oregon 1958-1960

Fellowship:

Fellow in Cardiology- University of Oregon Medical School, Portland, Oregon 1960-1962
Nephrology Fellow - Cardiovascular Research Institute, University of California Medical School, San Francisco, California 1962-1964

Research Interest:

Urinary biomarkers to identify toxic injury to the kidneys, value of serum biomarkers in chronic renal failure patients.

Representative Publications:

• Porter GA. Renal rehabilitation: effecting improvement through the team approach. Nephrology. 1997;3:221-229.
• Mueller PW, Price RG, Porter G. Proceedings of the Joint US/EU Workshop: urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. Ren Fail. 1997;19(4):501-504.
• Porter GA, Morin JP, Bernard A, Manley SE. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. V. Monitoring of individuals with elevated test patterns. Ren Fail. 1997:567-573.
• Goyer R, Eknoyan G, DeBroe ME, Buckalew VM, Mutti A, Porter GA, Morin JP. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. II. Nephrotoxins of significant frequency and economic impact. Ren Fail. 1997;19(4):523-534.
• Bennett WM, Porter GA. Analgesic nephropathy and the use of non-steroidal antiinflammatory drugs in renal patients: new insights. J Nephrol. 1998;11:70-75.
• Clinical Nephrotoxins: Renal injury from drugs and chemical. Ed. DeBroe ME, Porter GA, Bennett WM, Verpooten GA. Klewer Acad. Pub., 1998